rs76659072

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_025009.5(CEP135):​c.3265T>A​(p.Leu1089Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000426 in 1,613,780 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0023 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 2 hom. )

Consequence

CEP135
NM_025009.5 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 1.08

Publications

3 publications found
Variant links:
Genes affected
CEP135 (HGNC:29086): (centrosomal protein 135) This gene encodes a centrosomal protein, which acts as a scaffolding protein during early centriole biogenesis, and is also required for centriole-centriole cohesion during interphase. Mutations in this gene are associated with autosomal recessive primary microcephaly-8. [provided by RefSeq, Jun 2012]
CEP135 Gene-Disease associations (from GenCC):
  • microcephaly 8, primary, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0075767636).
BP6
Variant 4-56020725-T-A is Benign according to our data. Variant chr4-56020725-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210681.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0023 (351/152320) while in subpopulation AFR AF = 0.00818 (340/41574). AF 95% confidence interval is 0.00746. There are 3 homozygotes in GnomAd4. There are 161 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP135NM_025009.5 linkc.3265T>A p.Leu1089Ile missense_variant Exon 24 of 26 ENST00000257287.5 NP_079285.2 Q66GS9-1
CEP135XM_006714055.4 linkc.3232T>A p.Leu1078Ile missense_variant Exon 24 of 26 XP_006714118.1
CEP135XM_005265788.5 linkc.2194T>A p.Leu732Ile missense_variant Exon 17 of 19 XP_005265845.1
CEP135XM_011534412.2 linkc.1735T>A p.Leu579Ile missense_variant Exon 14 of 16 XP_011532714.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP135ENST00000257287.5 linkc.3265T>A p.Leu1089Ile missense_variant Exon 24 of 26 1 NM_025009.5 ENSP00000257287.3 Q66GS9-1
CEP135ENST00000506202.1 linkn.3215T>A non_coding_transcript_exon_variant Exon 17 of 19 1
CEP135ENST00000706801.1 linkn.1330T>A non_coding_transcript_exon_variant Exon 8 of 10

Frequencies

GnomAD3 genomes
AF:
0.00230
AC:
350
AN:
152202
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00818
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000533
AC:
134
AN:
251178
AF XY:
0.000405
show subpopulations
Gnomad AFR exome
AF:
0.00750
Gnomad AMR exome
AF:
0.000231
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000881
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000231
AC:
337
AN:
1461460
Hom.:
2
Cov.:
30
AF XY:
0.000204
AC XY:
148
AN XY:
727032
show subpopulations
African (AFR)
AF:
0.00846
AC:
283
AN:
33460
American (AMR)
AF:
0.000313
AC:
14
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39624
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5764
European-Non Finnish (NFE)
AF:
0.00000360
AC:
4
AN:
1111794
Other (OTH)
AF:
0.000530
AC:
32
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00230
AC:
351
AN:
152320
Hom.:
3
Cov.:
32
AF XY:
0.00216
AC XY:
161
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00818
AC:
340
AN:
41574
American (AMR)
AF:
0.000392
AC:
6
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68028
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000360
Hom.:
0
Bravo
AF:
0.00214
ESP6500AA
AF:
0.00499
AC:
22
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000659
AC:
80
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Jun 15, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 13, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CEP135-related disorder Benign:1
Mar 07, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.11
T
Eigen
Benign
0.063
Eigen_PC
Benign
-0.062
FATHMM_MKL
Benign
0.66
D
LIST_S2
Uncertain
0.87
D
M_CAP
Benign
0.0090
T
MetaRNN
Benign
0.0076
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.6
M
PhyloP100
1.1
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.094
Sift
Uncertain
0.018
D
Sift4G
Uncertain
0.054
T
Polyphen
0.94
P
Vest4
0.40
MVP
0.32
MPC
0.19
ClinPred
0.046
T
GERP RS
0.65
Varity_R
0.084
gMVP
0.28
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76659072; hg19: chr4-56886891; API